BRIEF published on 04/14/2026 at 07:05, 3 months 1 day ago PolyPeptide Group observe les spéculations du marché concernant une potentielle prise de contrôle Croissance Des Revenus Revue Stratégique Groupe Polypeptide Spéculation Du Marché Intérêt Pour La Prise De Contrôle
BRIEF published on 04/14/2026 at 07:05, 3 months 1 day ago PolyPeptide Group Observes Market Speculation Regarding Potential Takeover Revenue Growth Strategic Review PolyPeptide Group Market Speculation Takeover Interest
PRESS RELEASE published on 04/14/2026 at 07:00, 3 months 1 day ago PolyPeptide Group AG takes note of market rumors and speculation PolyPeptide Group AG acknowledges market rumors and speculation regarding potential takeover interest, conducting a review of strategic options in coordination with majority shareholder Draupnir Holding B.V Strategic Options PolyPeptide Group Shareholder Review Market Rumors Takeover Interest
BRIEF published on 04/08/2026 at 18:15, 3 months 7 days ago L'assemblée générale annuelle 2026 de PolyPeptide Group obtient un large consensus. Conseil D'administration Groupe Polypeptide Approbation De La Rémunération Assemblée Générale Annuelle 2026 États Financiers 2025
BRIEF published on 04/08/2026 at 18:15, 3 months 7 days ago PolyPeptide Group's AGM 2026 Yields Broad Approvals Board Of Directors PolyPeptide Group Compensation Approval AGM 2026 Financial Statements 2025
PRESS RELEASE published on 04/08/2026 at 18:10, 3 months 7 days ago PolyPeptide announces results of the annual General Meeting 2026 PolyPeptide Group AG announces successful results of the annual General Meeting 2026 where shareholders approved all proposals by a large majority Board Of Directors Shareholders Pharmaceutical PolyPeptide Group AGM 2026
BRIEF published on 03/19/2026 at 07:05, 3 months 27 days ago PolyPeptide élargit sa ligne de crédit pour renforcer sa structure financière Croissance Des Revenus Facilité De Crédit Flexibilité Financière Syndicat Bancaire Produits Pharmaceutiques Peptidiques
BRIEF published on 03/19/2026 at 07:05, 3 months 27 days ago PolyPeptide Expands Credit Facility to Enhance Financial Structure Revenue Growth Credit Facility Banking Syndicate Financial Flexibility Peptide Pharmaceuticals
PRESS RELEASE published on 03/19/2026 at 07:00, 3 months 27 days ago PolyPeptide strengthens financing structure through expansion of existing credit facility PolyPeptide Group AG strengthens financing structure by expanding existing credit facility to EUR 200 million, backed by UBS, ING Bank, Danske Bank, and Zürcher Kantonalbank Financing Credit Facility PolyPeptide UBS ING Bank
BRIEF published on 03/17/2026 at 07:05, 3 months 29 days ago PolyPeptide Announces 2026 Annual General Meeting Annual General Meeting Financial Statements Board Re-election PolyPeptide Group Compensation Approval
Published on 07/16/2026 at 00:40, 5 hours 14 minutes ago Revive Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement
Published on 07/15/2026 at 23:00, 6 hours 54 minutes ago Battery X Metals Completes First-Generation Proprietary Battery Adaptor for Tesla Model 3 and Model Y, Marking a Significant Commercial Readiness Milestone for its Patent-Pending Lithium-Ion Battery Rebalancing Platform
Published on 07/15/2026 at 22:45, 7 hours 9 minutes ago Mako Mining Announces Q2 2026 Production Results with Record Gold Sold of 14,610 Au oz., Revenues of ~US$63 Million and Cash and Securities Balance of US$112 Million
Published on 07/15/2026 at 22:15, 7 hours 39 minutes ago Loar Holdings Inc. Announces Date and Time for Second Quarter 2026 Earnings and Conference Call
Published on 07/15/2026 at 14:30, 15 hours 24 minutes ago Avant Brands Reports Q2 2026 Results Highlighted by 34% Growth in Recreational Revenue
Published on 07/16/2026 at 04:55, 59 minutes ago Finding Calm in the Roar: Hisense Creates More Inclusive FIFA World Cup 2026™ Experiences for Fans Across All 16 Host Cities
Published on 07/16/2026 at 01:01, 4 hours 53 minutes ago EQS-Adhoc: Circus Adjusts FY2026 Financial Guidance; Sharpens Focus on Operational Scalability
Published on 07/15/2026 at 20:14, 9 hours 40 minutes ago EQS-Adhoc: Bajaj Mobility AG: Preliminary figures for Q2 / 2026
Published on 07/15/2026 at 19:42, 10 hours 12 minutes ago EQS-Adhoc: Cherry SE: Adjusted EBITDA for the first half of 2026 significantly above prior-year operating result
Published on 07/15/2026 at 17:45, 12 hours 9 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2026
Published on 07/15/2026 at 17:45, 12 hours 9 minutes ago Half yearly report on the liquidity contract
Published on 07/15/2026 at 17:45, 12 hours 9 minutes ago Nombre total de droits de vote et actions composant le capital social au 30 juin 2026
Published on 07/15/2026 at 17:40, 12 hours 14 minutes ago Déclaration des transactions sur actions propres réalisées du 8 au 14 juillet 2026
